CoChat

Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic

Open access
Majchrzak, Kinga, Nelson, Michelle H., Bailey, Stefanie R., Bowers, Jacob S., Yu, Xue-Zhong, Rubinstein, Mark P., Himes, Richard A., Paulos, Chrystal M. · 2016 · Cancer Immunology, Immunotherapy
Cited by 47

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Cancer immunotherapy is one the most effective approaches for treating patients with tumors, as it bolsters the generation and persistence of memory T cells. In preclinical work, it has been reported that adoptively transferred CD4+ and CD8+ lymphocytes that secrete IL-17A (i.e., Th17 and Tc17 cells) regress tumors to a greater extent than IFN-γ+Th1 or Tc1 cells in vivo. Herein, we review the mechanisms underlying how infused Th17 and Tc17 cells regress established malignancies in clinically relevant mouse models of cancer. We also discuss how unique signaling cues—such as co-stimulatory molecules (ICOS and 41BB), cytokines (IL-12 and IL-23) or pharmaceutical reagents (Akt inhibitors, etc.)—can be exploited to bolster the therapeutic potential of IL-17+ lymphocytes with an emphasis on using this knowledge to improve next-generation clinical trials for patients with cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00262-016-1797-6

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 47

Metadata

Authors
Majchrzak, K., Nelson, M. H., Bailey, S. R., Bowers, J. S., Yu, X.-Z., Rubinstein, M. P., Himes, R. A., & Paulos, C. M.
Venue
Cancer Immunology, Immunotherapy
Published
2016-01-29
Volume
65
Issue
3
Pages
247-259
ISSN
  • 0340-7004 (ISSN-L)
  • 1432-0851
OpenAlex
W2252371475
Cited by
47
References
25
FWCI
2.52
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic. https://app.cochat.ai/papers/10.1007/s00262-016-1797-6
The paper
Majchrzak, K., Nelson, M. H., Bailey, S. R., Bowers, J. S., Yu, X.-Z., Rubinstein, M. P., Himes, R. A., & Paulos, C. M. (2016). Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-016-1797-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.